advanced search

<< Back To Home

Articles by N.C. Grassly on Trachoma, Polio, HIV, and the Seasonality of Infectious Diseases

Wednesday, 23rd of December 2015

 

Articles by N.C. Grassly on Trachoma, Polio, HIV, and the Seasonality of Infectious Diseases

Professor Nick Grassly, of Imperial College, London, has written on a broad variety of subjects, all related to the epidemiology, control and eradication of infectious diseases. Here is a sampling of his work from recent decades. He is so prolific that, in the polio section, I have bulleted, for the busy reader, those articles with a direct bearing on endgame issues and the inactivated polio vaccine.

If you read nothing else by Grassly, read his systematic review on 1- and 2-dose schedules of the inactivated polio vaccine from the Journal of Infectious Diseases, which is accessible online at http://jid.oxfordjournals.org/content/early/2014/03/13/infdis.jit601.full

If you read two things, go to “New Method for Estimating the Coverage of Mass Vaccination Campaigns Against Poliomyelitis From Surveillance Data,” accessible online at  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4655745/

If you read three things, read Grassly’s co-authored article on seasonality, accessible at http://www.ncbi.nlm.nih.gov/pubmed/16959647. A locus classicus, it has been cited 49 times by other authors.

Good reading.

BD

Trachoma

Using a nonparametric multilevel latent Markov model to evaluate diagnostics for trachoma. http://aje.oxfordjournals.org/content/177/9/913.long

The natural history of trachoma infection and disease in a Gambian cohort with frequent follow-up. http://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0000341#abstract1

Targeting antibiotics to households for trachoma control. http://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0000862

HIV/AIDS

Projecting the demographic impact of AIDS and the number of people in need of treatment: updates to the Spectrum projection package. http://sti.bmj.com/content/82/suppl_3/iii45.long

Improving projections at the country level: the UNAIDS Estimation and Projection Package 2005. http://sti.bmj.com/content/82/suppl_3/iii34.abstract

The future of the HIV pandemic. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2626235/

Uncertainty in estimates of HIV/AIDS: the estimation and application of plausibility bounds. http://www.ncbi.nlm.nih.gov/pubmed/15249697

The workbook approach to making estimates and projecting future scenarios of HIV/AIDS in countries with low level and concentrated epidemics. http://sti.bmj.com/content/80/suppl_1/i10.long

The UNAIDS Estimation and Projection Package: a software package to estimate and project national HIV epidemics. http://sti.bmj.com/content/80/suppl_1/i5.long

Maximising the global use of HIV surveillance data through the development and sharing of analytical tools. http://r4d.dfid.gov.uk/Output/188852/

Back to basics in HIV prevention: focus on exposure. http://www.bmj.com/content/326/7403/1384.long

The effectiveness of HIV prevention and the epidemiological context. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2566728/

Population dynamics of HIV-1 inferred from gene sequences. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1460489/

Mortality among human immunodeficiency virus type 2-positive villagers in rural Guinea-Bissau is correlated with viral genotype. http://jvi.asm.org/content/72/10/7895.long

Monitoring trends in HIV prevalence among young people, aged 15 to 24 years, in Manicaland, Zimbabwe. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3126756/

Seasonality

Seasonal infectious disease epidemiology. http://www.ncbi.nlm.nih.gov/pubmed/16959647

Poliomyelitis

The co-authored work of Grassly on endgame issues and IPV appears bulleted in the first five items.

1. The final stages of the global eradication of poliomyelitis. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3720038/
2. 2.      Impact of inactivated poliovirus vaccine on mucosal immunity: implications for the polio eradication endgame. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673562/pdf/ierv-14-1113.pdf
3. Polio eradication. Efficacy of inactivated poliovirus vaccine in India. http://www.ncbi.nlm.nih.gov/pubmed/25146288
4. Immunogenicity and effectiveness of routine immunization with 1 or 2 doses of inactivated poliovirus vaccine: systematic review and meta-analysis. http://jid.oxfordjournals.org/content/early/2014/03/13/infdis.jit601.full
5. The potential impact of routine immunization with inactivated poliovirus vaccine on wild-type or vaccine-derived poliovirus outbreaks in a posteradication setting. http://aje.oxfordjournals.org/content/178/10/1579.long

New Method for Estimating the Coverage of Mass Vaccination Campaigns Against Poliomyelitis From Surveillance Data. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4655745/

The role of older children and adults in wild poliovirus transmission. http://www.pnas.org/content/111/29/10604.full

The effect of mass immunisation campaigns and new oral poliovirus vaccines on the incidence of poliomyelitis in Pakistan and Afghanistan, 2001-11: a retrospective analysis. http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2812%2960648-5/fulltext

A statistical model of the international spread of wild poliovirus in Africa used to predict and prevent outbreaks. http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1001109#abstract1

Implications of a circulating vaccine-derived poliovirus in Nigeria. Implications of a circulating vaccine-derived poliovirus in Nigeria. http://www.nejm.org/doi/full/10.1056/NEJMoa0910074#t=article